Table 3.
Correlation between heparin binding epidermal growth factor expression and clinicopathological characteristics of colorectal cancers in cohort of human colorectal cancer tissues
| Clinicopathological variables |
Cohort tumor HB-EGF expression
|
P
value
|
||
|
Negative (n = 26)
|
Positive (n = 39)
|
|||
| Age (yr) | 65.72 (10.37) | 69.43 (7.98) | ||
| Gender | Female | 11 | 23 | > 0.05 |
| Male | 14 | 16 | ||
| Size of tumor (mm) | ≤ 10 | 5 | 7 | > 0.05 |
| > 10 | 21 | 32 | ||
| Lymphatic metastasis | Absent | 19 | 19 | > 0.05 |
| Present | 7 | 20 | ||
| Tumor differentiation | I-II | 12 | 24 | > 0.05 |
| III-IV | 14 | 15 | ||
| TNM stage | I-II | 11 | 8 | > 0.05 |
| III-IV | 15 | 31 | ||
| AJCC clinical stage according to 7th issue | 1 and 2A | 17 | 24 | > 0.05 |
| 3 and 3B | 9 | 15 | ||
HB-EGF: Heparin binding epidermal growth factor; AJCC: American Journal of Critical Care.